Keywords: takeda, first-half, profits, soar, back, strong, sales
Takeda first-half profits soar on the back of strong sales overseas
Article | 07 November 2001
Japan's largest drugmaker, Takeda Chemical Industries, has posted netincome for the fiscal half-year ended September 30, 2001, of 130.85 billion yen ($1.07 billion), a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
